Cognition Therapeutics Ownership | Who Owns Cognition Therapeutics?


OverviewForecastFinancialsChartTranscripts

Cognition Therapeutics Ownership Summary


Cognition Therapeutics is owned by 17.65% institutional investors, 0.85% insiders, and 81.50% retail investors. Bios capital management, lp is the largest institutional shareholder, holding 9.42% of CGTX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.52% of its assets in Cognition Therapeutics shares.

CGTX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCognition Therapeutics17.65%0.85%81.50%
SectorHealthcare Stocks 486.50%11.08%-397.59%
IndustryBiotech Stocks 304.14%11.08%-215.23%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Bios capital management, lp6.00M9.42%$1.86M
Vanguard group1.24M3.07%$868.94K
Acadian asset management701.94K1.10%$216.00K
Geode capital management352.35K0.87%$247.14K
Voss capital450.00K0.71%$139.41K
Cm management200.00K0.49%$140.26K
Blackrock152.58K0.45%$253.28K
Kestra advisory services177.43K0.44%$124.43K
American financial group205.00K0.32%$63.51K
State street121.85K0.30%$85.45K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bios capital management, lp6.00M2.56%$1.86M
Cm management200.00K0.13%$140.26K
American financial group205.00K0.02%$63.51K
Fca corp /tx51.47K0.01%$36.10K
Voss capital450.00K0.01%$139.41K
Castle wealth management44.01K0.01%$13.63K
Bangor savings bank34.02K0.00%$23.86K
Nwam42.78K0.00%$26.62K
Sigma planning147.99K0.00%$45.85K
Gratus capital18.42K0.00%$30.58K

Top Buyers

HolderShares% AssetsChange
Blackrock152.58K-96.76K
State street121.85K-59.10K
Empirical financial services, llc d.b.a. empirical wealth management48.00K0.00%48.00K
Nwam42.78K0.00%42.78K
Two sigma investments, lp53.69K0.00%42.32K

Top Sellers

HolderShares% AssetsChange
Awm investment company---650.00K
Alyeska investment group---500.00K
Sigma planning147.99K0.00%-460.40K
Timelo investment management---361.40K
Acadian asset management701.94K0.00%-305.65K

New Positions

HolderShares% AssetsChangeValue
Empirical financial services, llc d.b.a. empirical wealth management48.00K0.00%48.00K$14.87K
Nwam42.78K0.00%42.78K$26.62K
Envestnet asset management30.00K-30.00K$49.80K
Citadel advisors26.95K-26.95K$44.74K
Bryn mawr capital management23.34K0.00%23.34K$16.37K

Sold Out

HolderChange
Fmr-1.00
Jpmorgan chase-69.00
Opal wealth advisors-500.00
Coldstream capital management-1.24K
Sandy spring bank-2.00K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202548-11,241,507-3.32%174.99%18-10.00%7-36.36%
Mar 31, 20251-97.78%6,000,000-45.80%91.29%--100.00%--100.00%
Dec 31, 202430-23.08%10,129,593138.12%2522.62%13-18.75%650.00%
Sep 30, 202438-17.39%4,196,749-20.97%104.19%15-21.05%4-42.86%
Jun 30, 202446-5,310,353-25.11%153.56%19-24.00%7-12.50%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv988.30K1.52%-21.60K
Vanguard Institutional Extnd Mkt Idx Tr527.22K0.81%245.41K
Fidelity Extended Market Index194.94K0.31%-
BlackRock Extended Equity Market K64.70K0.16%-27.00
iShares Micro-Cap ETF64.20K0.10%-
Extended Equity Market Fund K62.76K0.10%-1.25K
Fidelity Total Market Index59.10K0.10%-
Fidelity Series Total Market Index48.20K0.08%-
Bridgeway Ultra-Small Company Market31.87K0.08%-44.83K
Spartan Extended Market Index Pool F29.39K0.05%-

Recent Insider Transactions


DateNameRoleActivityValue
Jan 31, 2025Ricciardi Lisa CEO & PresidentBuy$30.00K
Mar 14, 2024Ricciardi Lisa CEO & PresidentBuy$9.97K
Nov 29, 2022RICHSTONE ELLEN B-Buy$26.55K
Nov 28, 2022Fletcher Aaron G.L.-Buy$4.96K
Nov 28, 2022Fletcher Aaron G.L.-Buy$5.23K

Insider Transactions Trends


DateBuySell
2025 Q3--
2025 Q2--
2025 Q11-
2024 Q2--
2024 Q11-

CGTX Ownership FAQ


Who Owns Cognition Therapeutics?

Cognition Therapeutics shareholders are primarily institutional investors at 17.65%, followed by 0.85% insiders and 81.50% retail investors. The average institutional ownership in Cognition Therapeutics's industry, Biotech Stocks , is 304.14%, which Cognition Therapeutics falls below.

Who owns the most shares of Cognition Therapeutics?

Cognition Therapeutics’s largest shareholders are Bios capital management, lp (6M shares, 9.42%), Vanguard group (1.24M shares, 3.07%), and Acadian asset management (701.94K shares, 1.10%). Together, they hold 13.59% of Cognition Therapeutics’s total shares outstanding.

Does Blackrock own Cognition Therapeutics?

Yes, BlackRock owns 0.45% of Cognition Therapeutics, totaling 152.58K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 253.28K$. In the last quarter, BlackRock increased its holdings by 96.76K shares, a 173.34% change.

Who is Cognition Therapeutics’s biggest shareholder by percentage of total assets invested?

Bios capital management, lp is Cognition Therapeutics’s biggest shareholder by percentage of total assets invested, with 2.56% of its assets in 6M Cognition Therapeutics shares, valued at 1.86M$.

Who is the top mutual fund holder of Cognition Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Cognition Therapeutics shares, with 1.52% of its total shares outstanding invested in 988.3K Cognition Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools